Systemic Infusion of Expanded CD133+ Cells and Expanded CD133+ Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI

• Autori principali: Addeli B. B. Angulski (Autore), Luiz Guilherme A. Capriglione (Autore), Fabiane Barchiki (Autore), Paulo Brofman (Autore), Marco A. Stimamiglio (Autore), Alexandra C. Senegaglia (Autore), Alejandro Correa (Autore)
• Natura: Libro
• Pubblicazione: Hindawi Limited, 2019-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Myocardial infarction is a leading cause of death among all cardiovascular diseases. Cell therapies using a cell population enriched with endothelial progenitor cells (EPCs), expanded CD133+ cells, have promise as a therapeutic option for the treatment of ischemic areas after infarction. Recently, s...